Cannabinoid Encyclopedia

Focused research review

CB2 receptor immune/inflammation: what the research says

What evidence connects CB2 receptor biology with immune, inflammatory, microglial, neuroinflammatory, or pain-related mechanisms?

Updated July 2026 31 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined CB2 receptor immune/inflammation. This page brings together 6 human-study sources, 8 research reviews, and 17 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about CB2 receptor immune/inflammation.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on CB2 receptor immune/inflammation covers CB2; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about CB2 receptor immune/inflammation

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

CB2

This part of the literature focuses on CB2. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

6 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

8 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

17 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CB2 receptor immune/inflammation is not one kind of study. This source set includes 18 animal studies, 8 narrative or expert reviews, and 4 cell or laboratory studies. 3

The recorded populations or models include animal models (14 sources), people or patients (8 sources), and cells or tissue models (5 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms (31 sources). Closely related outcome names can still describe different measurements. 5

The CB2 receptor immune/inflammation source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

On this page, this source examines Cannabinoids activity involving CB2. 1

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
evidence still limited

animal study

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy.

On this page, this source examines Cannabinoids activity involving CB2. 2

Study type
animal study
Population or model
animal models
Outcome focus
cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

On this page, this source examines Cannabinoids activity involving CB2. 3

Study type
narrative or expert review
Outcome focus
cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
evidence still limited

narrative or expert review

Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders.

On this page, this source examines Cannabinoids activity involving CB2. 4

Study type
narrative or expert review
Population or model
cells or tissue models
Outcome focus
cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
evidence still limited

narrative or expert review

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

On this page, this source examines Cannabinoids activity involving CB2. 5

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
cB2 immune, inflammatory, microglial, neuroinflammatory, pain, or tissue-injury mechanisms
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on CB2 receptor immune/inflammation should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects CB2 receptor biology with immune, inflammatory, microglial, neuroinflammatory, or pain-related mechanisms?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    An overview of the cannabinoid type 2 receptor system and its therapeutic potential. narrative or expert review; evidence still limited PubMed 29794855 DOI 10.1097/aco.0000000000000616
  2. 2
    Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy. animal study; mechanism-focused research PubMed 39334169 DOI 10.1186/s12974-024-03221-5
  3. 3
    Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. narrative or expert review; evidence still limited PubMed 19152719 DOI 10.1017/s1462399409000957
  4. 4
    Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders. narrative or expert review; evidence still limited PubMed 40943579 DOI 10.3390/ijms26178657
  5. 5
    Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? narrative or expert review; evidence still limited PubMed 32471272 DOI 10.3390/ijms21113809
  6. 6
    CB₂: therapeutic target-in-waiting. narrative or expert review; evidence still limited PubMed 22197668 DOI 10.1016/j.pnpbp.2011.12.001
  7. 7
    Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders. narrative or expert review; evidence still limited PubMed 39264450 DOI 10.1007/s00213-024-06683-w
  8. 8
    The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. narrative or expert review; evidence still limited PubMed 20236042 DOI 10.2174/187152410790780145
  9. 9
    What we know and do not know about the cannabinoid receptor 2 (CB2). narrative or expert review; evidence still limited PubMed 24877594 DOI 10.1016/j.smim.2014.04.002
  10. 10
    A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling. animal study; mechanism-focused research PubMed 41875735 DOI 10.1016/j.phymed.2026.158068
  11. 11
    Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation. animal study; mechanism-focused research PubMed 36583304 DOI 10.1002/ptr.7710
  12. 12
    Cannabinoid CB2 receptors enhance high-fat diet evoked peripheral neuroinflammation. animal study; mechanism-focused research PubMed 39173999 DOI 10.1016/j.lfs.2024.123002
See all 31 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy. animal study; mechanism-focused research / 1 linked research note PubMed 39334169
  2. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. narrative or expert review; evidence still limited / 1 linked research note PubMed 19152719
  3. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease. animal study; mechanism-focused research / 1 linked research note PubMed 38662453
  4. CB₂: therapeutic target-in-waiting. narrative or expert review; evidence still limited / 1 linked research note PubMed 22197668
  5. Cannabinoid CB2 receptors enhance high-fat diet evoked peripheral neuroinflammation. animal study; mechanism-focused research / 1 linked research note PubMed 39173999
  6. Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders. narrative or expert review; evidence still limited / 1 linked research note PubMed 39264450
  7. Cannabinoid receptor 2 evolutionary gene loss makes parrots more susceptible to neuroinflammation. mechanism-focused research / 1 linked research note PubMed 36475439
  8. Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice. animal study; mechanism-focused research / 1 linked research note PubMed 37061199
  9. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. animal study; mechanism-focused research / 1 linked research note PubMed 18615177
  10. Cannabinoid receptor 2 activation mitigates lipopolysaccharide-induced neuroinflammation and sickness behavior in mice. animal study; mechanism-focused research / 1 linked research note PubMed 30666359
  11. An overview of the cannabinoid type 2 receptor system and its therapeutic potential. narrative or expert review; evidence still limited / 1 linked research note PubMed 29794855
  12. Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain. animal study; mechanism-focused research / 1 linked research note PubMed 37286073
  13. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. animal study; mechanism-focused research / 1 linked research note PubMed 26824325
  14. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. animal study; mechanism-focused research / 1 linked research note PubMed 23960212
  15. Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro. animal study; mechanism-focused research / 1 linked research note PubMed 38751621
  16. The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. narrative or expert review; evidence still limited / 1 linked research note PubMed 20236042
  17. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. animal study; mechanism-focused research / 1 linked research note PubMed 12823482
  18. Cannabinoid Type 2 Receptor System Modulates Paclitaxel-Induced Microglial Dysregulation and Central Sensitization in Rats. animal study; mechanism-focused research / 1 linked research note PubMed 30414958
  19. Cannabidiol-rich non-psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2-mediated microglial neuroinflammation. animal study; mechanism-focused research / 1 linked research note PubMed 36583304
  20. A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling. animal study; mechanism-focused research / 1 linked research note PubMed 41875735
  21. Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Inflammatory Bowel Disease. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40332343
  22. CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathy. animal study; mechanism-focused research / 1 linked research note PubMed 41383775
  23. What we know and do not know about the cannabinoid receptor 2 (CB2). narrative or expert review; evidence still limited / 1 linked research note PubMed 24877594
  24. Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 40791361
  25. Cannabinoid Receptor 2 (CB2) in Macrophages: A Promising Clinical Target for Immune Disorders. narrative or expert review; evidence still limited / 1 linked research note PubMed 40943579
  26. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. animal study; mechanism-focused research / 1 linked research note PubMed 16086683
  27. Cannabinoid receptor 2 affect the inflammatory response in periodontitis by regulating macrophage M1/M2 polarization. animal study; mechanism-focused research / 1 linked research note PubMed 41310604
  28. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. animal study; mechanism-focused research / 1 linked research note PubMed 18247131
  29. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? narrative or expert review; evidence still limited / 1 linked research note PubMed 32471272
  30. Cannabinoid receptor type 2 agonist GP1a attenuates macrophage activation induced by M. bovis-BCG by inhibiting NF-κB signaling. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 39538989
  31. Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 41740200